Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
TransAct Technologies Inc (TACT)
NASDAQInformation TechnologyComputer HardwareSnapshot 2026-11-04
$5.270.00%
Close 2026-11-04 · 1-day change
NASDAQInformation TechnologyComputer HardwareSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for TACT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Implement $3 million share repurchase program | The company started a $3 million share buyback. | Intact | No meaningful share repurchases executed by end of FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
TACT is a small-cap execution story, not a proven durable compounder: it remains loss-making and carries elevated risk. The long-term thesis is watchful, with recurring revenue growth offering progress but recent momentum weakening.
The valuation model describes TACT as cheap versus peers, while also showing a modest peer premium; model confidence is low. The expectations gap is negative, so the snapshot suggests expectations are not especially demanding, but it does not provide enough evidence to say exactly what the market assumes.
Near term, results are at risk: the company has a run of consecutive earnings misses, and the estimated miss probability is 39%. In 2026-Q1, recurring FST revenue grew 26% year over year and net sales rose 10%, but company momentum fell from 33.3 to 17.6; management has reaffirmed guidance as of 2026-08-11. Management is progressing on software and recurring revenue, while the CFO transition is mixed and no repurchase volumes have been reported.
The next earnings call is a key test: a guidance cut would be a negative, while maintaining guidance would preserve the current footing. Over the multi-year view, the thesis also depends on recurring revenue growth continuing and the announced acquisition supporting execution. Fed rate cuts or steadier results from major technology companies could improve the sector backdrop, but the evidence for their effect on TACT is uncertain.
For the next 1 to 3 years, TACT has signs of revenue progress but remains a loss-making, elevated-risk business with weaker recent momentum and a meaningful near-term earnings watch. The thesis depends on sustained recurring revenue growth and steadier execution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| New CFO hire may help stabilize management. |
| Intact |
| Further disruptive management changes or leadership departures in 2026 |
CFO transition completed 2026-06-29 vs mid-2026 target CFO transition finalized in June 2026; no subsequent executive departures or disruptive changes reported. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve adjusted EBITDA of $0.8-$1.5 million in 2026 | Profit should improve to $0.8-$1.5 million adjusted EBITDA. | Improving | Adjusted EBITDA falls below $0.8 million in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Increase revenue to $55-$57 million in 2026 | A primary condition in TransAct Technologies Inc's published investment case. The stated target is ~$56 million. | Intact | Revenue falls below $50 million in FY26 | Revenue: $13.948M FY2026-Q2; GAAP. Published target: ~$56 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 14, 202613,948,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.10 → $-0.14 · observed estimates
$0.06B → $0.06B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-07-25 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-07-26 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-07-27 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-07-28 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-07-29 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-07-30 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-07-31 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-01 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-02 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-03 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-04 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-05 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-06 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-08 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-09 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-10 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-12 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-13 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-14 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-15 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-16 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-17 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-18 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-19 | $-0.10 | $57,200,000 | 1 / 1 |
| 2026-08-20 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-08-21 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-08-22 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-08-23 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-08-24 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-08-25 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-08-26 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-08-27 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-08-28 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-08-29 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-08-30 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-08-31 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-01 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-02 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-03 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-04 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-05 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-06 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-07 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-08 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-09 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-10 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-11 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-12 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-13 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-14 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-15 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-16 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-17 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-18 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-19 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-20 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-21 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-22 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-23 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-24 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-25 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-26 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-27 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-28 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-29 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-09-30 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-01 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-02 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-03 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-04 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-05 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-06 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-07 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-08 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-09 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-10 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-11 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-12 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-13 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-14 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-15 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-16 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-17 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-18 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-19 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-20 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-21 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-22 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-23 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-24 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-25 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-26 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-27 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-28 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-29 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-30 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-10-31 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-11-01 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-11-02 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-11-03 | $-0.14 | $58,300,000 | 1 / 1 |
| 2026-11-04 | $-0.14 | $58,300,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.